Global Market Intelligence Service (GMIS) News Article:
European Medicines Verification Organization (EMVO) Published Onboarding Deadlines
Monday, 15th January 2018
Dear (future) On-boarding Partners,
With the deadline for the Falsified Medicines Directive (FMD) approaching, EMVO has issued guidance as it relates to the On-boarding process for manufacturers. This guidance advises all On-Boarding Partners and future On-Boarding Partners that the final opportunity to on-board into EMVO with a guarantee of making compliance deadlines is June 2018.” Due to the expected wave of OBP and the time required on their end to onboard all of them, the Hub will not be able to guarantee the completion of the onboarding process in time for all companies who fail to complete the process before the June deadline.
In order to encourage manufacturers to on-board sooner rather than later, the EMVO is offering discounted fees for organizations that complete steps 1.1 – 2.4 of the on-boarding process prior to June 15, 2018. . Please refer to the tables below:
The OBP Participation Agreement does not deal with the technical integration for automatic posting of serialized data, however you cannot begin any integration work until this is completed. The EMVO On-boarding process hands your company the keys to initiate your own EU technical integration process.
Contact Excellis Health Solutions & GMIS
- For additional information, specifically related to EMVO please see the information on the Excellis Europe website.
- Please reach out with any questions to GMIS@excellishealth.com
- Excellis Health Solutions – https://excellishealth.com/contact/
Excellis Health Solutions, LLC